183 related articles for article (PubMed ID: 26773310)
1. Hematologic malignancies in South Africa 2000-2006: analysis of data reported to the National Cancer Registry.
Schonfeld SJ; Erdmann F; Wiggill T; Singh E; Kellett P; Babb C; Schüz J
Cancer Med; 2016 Apr; 5(4):728-38. PubMed ID: 26773310
[TBL] [Abstract][Full Text] [Related]
2. Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004-2013.
Oelofse D; Truter I
Cancer Epidemiol; 2018 Apr; 53():166-171. PubMed ID: 29462765
[TBL] [Abstract][Full Text] [Related]
3. Age standardized incidence rates of oral cancer in South Africa, 1988-1991.
Hille JJ; Shear M; Sitas F
J Dent Assoc S Afr; 1996 Dec; 51(12):771-6. PubMed ID: 9462036
[TBL] [Abstract][Full Text] [Related]
4. Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
Leak SA; Mmbaga LG; Mkwizu EW; Mapendo PJ; Henke O
PLoS One; 2020; 15(5):e0232848. PubMed ID: 32374771
[TBL] [Abstract][Full Text] [Related]
5. Childhood cancer incidence patterns by race, sex and age for 2000-2006: a report from the South African National Cancer Registry.
Erdmann F; Kielkowski D; Schonfeld SJ; Kellett P; Stanulla M; Dickens C; Kaatsch P; Singh E; Schüz J
Int J Cancer; 2015 Jun; 136(11):2628-39. PubMed ID: 25363616
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
7. Global burden of hematologic malignancies and evolution patterns over the past 30 years.
Zhang N; Wu J; Wang Q; Liang Y; Li X; Chen G; Ma L; Liu X; Zhou F
Blood Cancer J; 2023 May; 13(1):82. PubMed ID: 37193689
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
9. Meeting the challenge of hematologic malignancies in sub-Saharan Africa.
Gopal S; Wood WA; Lee SJ; Shea TC; Naresh KN; Kazembe PN; Casper C; Hesseling PB; Mitsuyasu RT
Blood; 2012 May; 119(22):5078-87. PubMed ID: 22461494
[TBL] [Abstract][Full Text] [Related]
10. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
Pulte D; Jansen L; Brenner H
Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
[TBL] [Abstract][Full Text] [Related]
13. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
14. Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.
Tzeng HE; Lin CL; Tsai CH; Tang CH; Hwang WL; Cheng YW; Sung FC; Chung CJ
PLoS One; 2013; 8(7):e68041. PubMed ID: 23844152
[TBL] [Abstract][Full Text] [Related]
15. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
16. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.
Dandoit M; Mounier M; Guy J; Petrella T; Girard S; Casasnovas RO; Martin L; Bonnetain F; Maynadié M
Leuk Lymphoma; 2015 Apr; 56(4):1050-7. PubMed ID: 25166007
[TBL] [Abstract][Full Text] [Related]
18. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years.
Elidrissi Errahhali M; Elidrissi Errahhali M; Boulouiz R; Ouarzane M; Bellaoui M
BMC Cancer; 2016 Feb; 16():159. PubMed ID: 26915519
[TBL] [Abstract][Full Text] [Related]
19. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
20. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.
Wabinga HR; Parkin DM; Wabwire-Mangen F; Mugerwa JW
Int J Cancer; 1993 Apr; 54(1):26-36. PubMed ID: 8478145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
